{"id":701436,"date":"2022-10-26T17:35:04","date_gmt":"2022-10-26T21:35:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/"},"modified":"2022-10-26T17:35:04","modified_gmt":"2022-10-26T21:35:04","slug":"alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/","title":{"rendered":"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">REYKJAVIK, Iceland , Oct.  26, 2022  (GLOBE NEWSWIRE) &#8212; Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in the Jefferies London Healthcare Conference from November 15<sup>th<\/sup> to November 17<sup>th<\/sup>.<\/p>\n<p align=\"left\">The Alvotech team is scheduled to present on November 17, 2022, at 10:25 am GMT and will host investor meetings at the conference through November 17, 2022.<\/p>\n<p>Following the conference, a webcast of Alvotech\u2019s presentation will be available in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=USsA7lPn8anjbkkezhUAz4zFpa8U-8TfJ1Gx-YSl7Dv2G6TbyKqYag5zea8_7HFOwMa0cnUtbknZl9Hcgw5Hvivr2nuqvt-bEV5kkN7hRNE=\" rel=\"nofollow noopener\" target=\"_blank\">Investors Section<\/a> of Alvotech\u2019s website under <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VcMCzXb43o-5pKi9l2kNM17THzO2-fY8NAVgKuROOixZyXhwcn_KZde-mXPE1hK2OglbTdw-pf9X_ZMImLGvCx7JkjgCNfxA2gaDU-uw0U4SPWlkseHMyQ284aVjJE8iSk8QAFEBWBcCV-tKHFkkQno0drOhzpb4x95uunOMxaQ=\" rel=\"nofollow noopener\" target=\"_blank\">News and Events \u2013 Events and Presentations<\/a>, for 90 days.<\/p>\n<p>\n        <strong>About Alvotech<\/strong>\n      <\/p>\n<p>Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products, and services, enabled by a fully integrated approach and broad in-house capabilities. Alvotech\u2019s current pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. Alvotech\u2019s commercial partners include Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd. (US), STADA Arzneimittel AG (EU), Fuji Pharma Co., Ltd (Japan), Cipla\/Cipla Gulf\/Cipla Med Pro (Australia, New Zealand, South Africa\/Africa), JAMP Pharma Corporation (Canada), Yangtze River Pharmaceutical (Group) Co., Ltd. (China), DKSH (Taiwan, Hong Kong, Cambodia, Malaysia, Singapore, Indonesia, India, Bangladesh and Pakistan), YAS Holding LLC (Middle East and North Africa), Abdi Ibrahim (Turkey), Kamada Ltd. (Israel), Mega Labs, Stein, Libbs, Tuteur and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines, and South Korea). Each commercial partnership covers a unique set of product(s) and territories. Except as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made available by its partners. For more information, please visit www.alvotech.com. None of the information on the Alvotech website shall be deemed part of this press release.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><\/p>\n<p>        <strong>Alvotech Investor Relations and Global Communications<\/strong><br \/>\n        <br \/>Benedikt Stefansson<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FRhusJRu3ly6RpW1AdMK5cSBakerzBCRuGz0B_2Vn8TLGb2nCOKmiOQZ5behuFz_1q5FvtOUYsjeLXFzzTl7bEfN8eZCxQeC-GnPDTU7ier7xD8EtIGTCTDZJehfpwqr\" rel=\"nofollow noopener\" target=\"_blank\">alvotech.ir[at]alvotech.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/ZTMwNzJjMDMtY2YxYS00MzZkLTllNTMtNGRmNDcxYTU5YjZmLTEyNDUzODY=\/tiny\/Alvotech.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) &#8212; Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in the Jefferies London Healthcare Conference from November 15th to November 17th. The Alvotech team is scheduled to present on November 17, 2022, at 10:25 am GMT and will host investor meetings at the conference through November 17, 2022. Following the conference, a webcast of Alvotech\u2019s presentation will be available in the Investors Section of Alvotech\u2019s website under News and Events \u2013 Events and Presentations, for 90 days. About Alvotech Alvotech is a biotech company, founded by Robert Wessman, focused solely on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-701436","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) &#8212; Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in the Jefferies London Healthcare Conference from November 15th to November 17th. The Alvotech team is scheduled to present on November 17, 2022, at 10:25 am GMT and will host investor meetings at the conference through November 17, 2022. Following the conference, a webcast of Alvotech\u2019s presentation will be available in the Investors Section of Alvotech\u2019s website under News and Events \u2013 Events and Presentations, for 90 days. About Alvotech Alvotech is a biotech company, founded by Robert Wessman, focused solely on the &hellip; Continue reading &quot;Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-26T21:35:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November\",\"datePublished\":\"2022-10-26T21:35:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/\"},\"wordCount\":391,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/\",\"name\":\"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==\",\"datePublished\":\"2022-10-26T21:35:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/","og_locale":"en_US","og_type":"article","og_title":"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November - Market Newsdesk","og_description":"REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) &#8212; Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in the Jefferies London Healthcare Conference from November 15th to November 17th. The Alvotech team is scheduled to present on November 17, 2022, at 10:25 am GMT and will host investor meetings at the conference through November 17, 2022. Following the conference, a webcast of Alvotech\u2019s presentation will be available in the Investors Section of Alvotech\u2019s website under News and Events \u2013 Events and Presentations, for 90 days. About Alvotech Alvotech is a biotech company, founded by Robert Wessman, focused solely on the &hellip; Continue reading \"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-26T21:35:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November","datePublished":"2022-10-26T21:35:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/"},"wordCount":391,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/","name":"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==","datePublished":"2022-10-26T21:35:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc1MzEzOCM0MDE0MDc5MzEjMjIzMzgzMw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-participate-in-upcoming-jefferies-london-healthcare-conference-in-november\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/701436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=701436"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/701436\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=701436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=701436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=701436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}